The Targeted Drug Delivery Market defines the process by which the drugs get delivered and marketed for the treatment of diseases with minimal side effects while making sure that the drugs reach the target cells within the body. This targeted drug delivery is a novel approach towards enhancing therapeutic efficacy against different diseases like cancer, cardiovascular diseases and neurological disorders because therapeutic agents may be delivered with high efficiency and selectivity with the help of techniques like nanoparticles and liposomes and monoclonal antibodies.

The targeting DNA repair drugs market encompasses a specialized segment of oncology and genetic disorder therapeutics focused on modulating DNA repair mechanisms. These drugs are designed to either inhibit or enhance the cell's natural ability to repair DNA damage, depending on the therapeutic goal. Most commonly used in cancer treatment, they exploit the defective DNA repair pathways in cancer cells to increase their vulnerability to treatments like chemotherapy, radiation, and immunotherapy. By selectively targeting repair pathways such as homologous recombination (HR) or base excision repair (BER), these drugs offer a precision medicine approach to cancer therapy.